In a rat model of pulmonary fibrosis, inhibition of the VEGF/VEGFR pathway with the angiogenesis inhibitor endostatin has been demonstrated to ameliorate pulmonary fibrogenesis (Wan et al., 2013). The gene discussed is VEGFA; the disease is pulmonary fibrosis.